Finance

Beta
Lists
688193:SHA
Shanghai Rendu Biotechnology Co Ltd
CNÂ¥52.10
-2.65%
(-1.42) 1D
Jun 12, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688193...
Open
CNÂ¥53.65
High
CNÂ¥54.88
Low
CNÂ¥51.71
Mkt. cap
2.09B
Avg. vol.
918.02K
Volume
655.52K
Dividend
2.21%
Quarterly dividend
CNÂ¥0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
146.05
52-wk high
CNÂ¥63.56
52-wk low
CNÂ¥37.94
EPS
CNÂ¥0.36
No. of employees
239
Open
CNÂ¥53.65
High
CNÂ¥54.88
Low
CNÂ¥51.71
Mkt. cap
2.09B
Avg. vol.
918.02K
Volume
655.52K
Dividend
2.21%
Quarterly dividend
CNÂ¥0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
146.05
52-wk high
CNÂ¥63.56
52-wk low
CNÂ¥37.94
EPS
CNÂ¥0.36
No. of employees
239
News stories
From sources across the web
About Shanghai Rendu Biotechnology Co Ltd
CEO-
Employees239
FoundedJun 13, 2007
Headquarters-
SectorMedical device
Websiterdbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
40.56M
37.91M
42.79M
42.08M
Cost of goods sold
9.10M
7.93M
9.05M
10.01M
Cost of revenue
9.10M
7.93M
9.05M
10.01M
Research and development expenses
8.14M
9.26M
8.94M
6.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.09M
24.41M
30.04M
22.68M
Operating expense
37.88M
23.43M
45.54M
29.53M
Total operating expenses
46.98M
31.36M
54.59M
39.54M
Operating income
-6.42M
6.55M
-11.80M
2.54M
Other non operating income
-26.43K
35.50K
13.12M
-49.46K
EBT including unusual items
209.72K
6.58M
2.88M
5.47M
EBT excluding unusual items
-3.09M
8.38M
3.91M
5.91M
Income tax expense
-607.31K
1.60M
-196.52K
474.90K
Effective tax rate
-289.57%
24.35%
-6.83%
8.68%
Other operating expenses
1.53M
-2.78M
-682.33K
-60.22K
Net income
817.04K
4.98M
3.07M
5.00M
Net profit margin
2.01%
13.12%
7.18%
11.87%
Earnings per share
-
-
-
-
Interest and investment income
3.44M
1.84M
2.59M
3.47M
Interest expense
-43.08K
-82.10K
-
-49.67K
Net interest expenses
3.40M
1.76M
2.59M
3.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.91M
10.08M
-8.38M
-
Gain or loss from assets sale
-7.32K
7.32K
386.31K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer